ID

14001

Descrição

the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient; ODM derived from: https://clinicaltrials.gov/show/NCT01766375

Link

https://clinicaltrials.gov/show/NCT01766375

Palavras-chave

  1. 21/03/2016 21/03/2016 -
Transferido a

21 de março de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Acute Myeloid Leukemia NCT01766375

Eligibility Acute Myeloid Leukemia NCT01766375

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
Age: 18~50
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
Received peripheral blood hematopoietic stem cell transplantation from siblings or unrelated allogeneic donors with identical matching of hla or 1 alleles mismatched.
Descrição

Peripheral Stem Cell Transplantation

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0242602
Diagnosis: refer to 2011 edition of aml china guideline for the diagnosis and treatment and diagnosis standards of high-risk acute myeloid leukemia developed through literatures (see appendix b);
Descrição

Acute Erythroblastic Leukemia

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023440
Under general condition, ecog score ≤ 1;
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
Normal cardiac functions
Descrição

Cardiac function

Tipo de dados

boolean

Normal liver and renal function: blood bilirubin≤35 μ mol\/l, ast/alt lower than twice in the upper limit of normal value, serum creatinine≤ 150 μ mol\/l;
Descrição

Renal and Liver function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
Subjects have signed the informed consent form.
Descrição

Informed consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
Severe uncontrolled infection before transplantation;
Descrição

Infection

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3714514
With contraindications of idarubicin
Descrição

Idarubicin

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0020789
Reached the maximum cumulative dose of anthracyclines, for instance, dnr≥ 450mg/m2, mitoxantrone≥140mg/m2, the total cumulative dose of idarubicin≥ 300mg/m2;
Descrição

Anthracycline Antibiotics

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0003234
The other conditions that do not meet the inclusion criteria.
Descrição

Inclusion criteria

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2827031
Withdrawal criteria:
Descrição

Withdrawal

Tipo de dados

integer

Alias
UMLS CUI [1]
C2349954

Similar models

Eligibility Acute Myeloid Leukemia NCT01766375

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
Age: 18~50
boolean
C0001779 (UMLS CUI [1])
Peripheral Stem Cell Transplantation
Item
Received peripheral blood hematopoietic stem cell transplantation from siblings or unrelated allogeneic donors with identical matching of hla or 1 alleles mismatched.
boolean
C0242602 (UMLS CUI [1])
Acute Erythroblastic Leukemia
Item
Diagnosis: refer to 2011 edition of aml china guideline for the diagnosis and treatment and diagnosis standards of high-risk acute myeloid leukemia developed through literatures (see appendix b);
boolean
C0023440 (UMLS CUI [1])
ECOG performance status
Item
Under general condition, ecog score ≤ 1;
boolean
C1520224 (UMLS CUI [1])
Cardiac function
Item
Normal cardiac functions
boolean
Renal and Liver function
Item
Normal liver and renal function: blood bilirubin≤35 μ mol\/l, ast/alt lower than twice in the upper limit of normal value, serum creatinine≤ 150 μ mol\/l;
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Informed consent
Item
Subjects have signed the informed consent form.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Infection
Item
Severe uncontrolled infection before transplantation;
boolean
C3714514 (UMLS CUI [1])
Idarubicin
Item
With contraindications of idarubicin
boolean
C0020789 (UMLS CUI [1])
Anthracycline Antibiotics
Item
Reached the maximum cumulative dose of anthracyclines, for instance, dnr≥ 450mg/m2, mitoxantrone≥140mg/m2, the total cumulative dose of idarubicin≥ 300mg/m2;
boolean
C0003234 (UMLS CUI [1])
Inclusion criteria
Item
The other conditions that do not meet the inclusion criteria.
boolean
C2827031 (UMLS CUI [1])
Item
Withdrawal criteria:
integer
C2349954 (UMLS CUI [1])
Code List
Withdrawal criteria:
CL Item
Those do not meet the inclusion criteria or meet the exclusion criteria after reviewing (1)
C2827031 (UMLS CUI-1)
CL Item
Patient withdraws the informed consent form (2)
C0021430 (UMLS CUI-1)
CL Item
Patient violates the clinical study protocol (3)
C2348563 (UMLS CUI-1)
CL Item
Patient experiences severe adverse events that treatment has to be terminated (4)
C0877248 (UMLS CUI-1)
CL Item
Patient that considered no longer fit to complete clinical trials by researchers. (5)
C0525058 (UMLS CUI-1)

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial